NEUARTIGE VERBINDUNGEN

European patent · EP1036076 · Deleted

Register entry

Publication number
EP1036076
Application number
EP98962754
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 1, 1998
Published
Sep 20, 2000
Granted
Sep 4, 2002
Deleted
Dec 31, 2005
Reason
Annual fee unpaid
IPC classes
C07D 487/04 (2006.01)
C07D 495/04 (2006.01)
C07D 491/04 (2006.01)
A61K 31/50 (2006.01)
A61K 31/40 (2006.01)
A61K 31/38 (2006.01)
A61K 31/34 (2006.01)
A61K 31/415 (2006.01)
Priority
SE 9704542 05.12.1997
SE 9801989 04.06.1998
PCT application
PCT/SE1998/002191 01.12.1998
PCT publication
WO1999/029695 17.06.1999
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 15, 2006

    Deleted, fee unpaid

    Published in +pat+ No 15 in 2006

  2. Sep 13, 2002

    Granted

    Published in +pat+ No 17 in 2002

Parties

Holder

AstraZeneca UK Limited

15 Stanhope Gate, London W1Y 6LN, GB

Inventor

BANTICK, John

Loughborough, Leics. LE11 5RH, GB

COOPER, Martin

Loughborough, Leics. LE11 5RH, GB

THORNE, Philip

Loughborough, Leics. LE11 5RH, GB

PERRY, Matthew

Loughborough, Leics. LE11 5RH, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.